Coverage
-
March 16, 2017
Cephalon Inc. has settled a whistleblower's False Claims Act suit over the company's alleged off-label promotion of its narcolepsy drug Provigil, according to an order filed in Pennsylvania federal court Thursday.
7 other articles on this case.
View all »